-- 2026年4月28日，持股10%的董事、董事长兼首席执行官相川义之（Yoshiyuki Aikawa）出售了SBC医疗集团控股公司（SBC）465,000股股份，套现1,405,463美元。根据向美国证券交易委员会（SEC）提交的4号表格文件，相川义之目前共控制该公司84,701,060股普通股，其中直接持有78,839,460股，间接控制5,861,600股。 SEC文件链接： https://www.sec.gov/Archives/edgar/data/1930313/000149315226019703/xslF345X05/ownership.xml
Related Articles
Equities
Update: -- Parex Resources Announcing Preliminary Q1 Results; Expects To generate FFO of US$114 million and FFO per share of $1.18
$PXT.TO
Equities
Parex Resources Announcing Preliminary Q1 Results; Expects To generate FFO of $114 million and FFO per share of $1.18
$PXT.TO
Research
Research Alert: Xpo Q1 Earnings Beat As Margins Expand And Tonnage Turns Positive
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:XPO reported Q1 EPS of $1.01 vs. $0.73 a year ago, beating consensus by $0.13, while revenue of $2.1B grew 7% and beat estimates by $60M. Adjusted EBITDA surged 15% to $319M, demonstrating accelerating momentum across the business. We believe the combination of margin expansion, positive volume inflection, and strong cash generation supports XPO's trajectory toward accelerating free cash flow generation. North American LTL performance was solid, with adjusted operating ratio improving 200 bps to 83.9% and 20% growth in adjusted operating income. Critically, tonnage per day turned positive at +0.1% vs. Q4 2025's -4.5% decline, marking an inflection point and suggesting early demand stabilization signs. Yield growth excluding fuel remained robust at 4.0%, supported by service improvements and AI-driven network optimization, while cash from operations grew 29% to $183M. In our view, XPO's insourcing strategy and operational leverage position the company well for continued margin expansion and cash flow growth.
$XPO